| TA86 |
Gastrointestinal stromal tumours - imatinib (TA86) |
|
-
-
Imatinib for gastrointestinal stromal tumours
This guidance has been partially updated by TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib. See the guidance and the quick reference guide for more information.
-
Other information
How this guidance was produced
Background information
- Review decision, February 2008
- Review decision, February 2007
- Review proposal, October 2007
- TA86 Gastrointestinal stromal tumours - imatinib: review proposal
- TA86 Gastro-intestinal stromal tumours (GIST) - imatinib: distribution list
- NICE issues guidance on the use of imatinib for the treatment of gastrointestinal stromal tumours
- Assessment report
This page was last updated: 08 February 2011
-
-
Guidance formats
-
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guidance
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
Full Guidance
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.
